BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei Y, Li J, Qing J, Huang M, Wu M, Gao F, Li D, Hong Z, Kong L, Huang W, Lin J. Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking. PLoS One 2016;11:e0148181. [PMID: 26845440 DOI: 10.1371/journal.pone.0148181] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Qiu Y, Zhou L, Hu Y, Bao Y. Discovery of promising FtsZ inhibitors by E-pharmacophore, 3D-QSAR, molecular docking study, and molecular dynamics simulation. J Recept Signal Transduct Res 2019;39:154-66. [PMID: 31355691 DOI: 10.1080/10799893.2019.1638404] [Reference Citation Analysis]
2 Oraby AK, Gardner CL, Needle RF, Kofahi HM, Everard KR, Taylor NGA, Rutihinda SG, Barry JP, Hirasawa K, Georghiou PE, Russell RS. A Novel Small Molecule Inhibits Hepatitis C Virus Propagation in Cell Culture. Microbiol Spectr 2021;9:e0043921. [PMID: 34319169 DOI: 10.1128/Spectrum.00439-21] [Reference Citation Analysis]
3 Jadhav DA. An enhanced and secured predictive model of Ada-Boost and Random-Forest techniques in HCV detections. Materials Today: Proceedings 2022;51:186-95. [DOI: 10.1016/j.matpr.2021.05.071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Pathania S, Rawal RK, Singh PK. RdRp (RNA-dependent RNA polymerase): A key target providing anti-virals for the management of various viral diseases. J Mol Struct 2022;1250:131756. [PMID: 34690363 DOI: 10.1016/j.molstruc.2021.131756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ebenezer O, Damoyi N, Shapi M. Predicting New Anti-Norovirus Inhibitor With the Help of Machine Learning Algorithms and Molecular Dynamics Simulation-Based Model. Front Chem 2021;9:753427. [PMID: 34869204 DOI: 10.3389/fchem.2021.753427] [Reference Citation Analysis]
6 Gawriljuk VO, Foil DH, Puhl AC, Zorn KM, Lane TR, Riabova O, Makarov V, Godoy AS, Oliva G, Ekins S. Development of Machine Learning Models and the Discovery of a New Antiviral Compound against Yellow Fever Virus. J Chem Inf Model 2021;61:3804-13. [PMID: 34286575 DOI: 10.1021/acs.jcim.1c00460] [Reference Citation Analysis]
7 El-Hassab MAE, El-Bastawissy EE, El-Moselhy TF. Identification of potential inhibitors for HCV NS5b of genotype 4a by combining dynamic simulation, protein-ligand interaction fingerprint, 3D pharmacophore, docking and 3D QSAR. J Biomol Struct Dyn 2020;38:4521-35. [PMID: 31647392 DOI: 10.1080/07391102.2019.1685005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
8 Akher FB, Farrokhzadeh A, Ramharack P, Shunmugam L, Van Heerden FR, Soliman MES. Discovery of novel natural flavonoids as potent antiviral candidates against hepatitis C virus NS5B polymerase. Med Hypotheses 2019;132:109359. [PMID: 31466018 DOI: 10.1016/j.mehy.2019.109359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Saigo K, Ozaki S, Ueda K, Ryo R, Tatsumi E, Yamaguchi N. [An aged patient with acute myelogenous leukemia complicated with liver cirrhosis: successful treatment with low-dose cytosine arabinoside]. Gan To Kagaku Ryoho. 1989;16:2441-2444. [PMID: 2751321 DOI: 10.1016/j.biopha.2016.08.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
10 Zhao D, He HS, Wang WJ, Liu J, Du H, Wu M, Tan X. Distribution and Driving Factors of Forest Swamp Conversions in a Cold Temperate Region. Int J Environ Res Public Health 2018;15:E2103. [PMID: 30257466 DOI: 10.3390/ijerph15102103] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Ganesan A, Barakat K. Applications of computer-aided approaches in the development of hepatitis C antiviral agents. Expert Opin Drug Discov 2017;12:407-25. [PMID: 28164720 DOI: 10.1080/17460441.2017.1291628] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
12 Caruso A, Ceramella J, Iacopetta D, Saturnino C, Mauro MV, Bruno R, Aquaro S, Sinicropi MS. Carbazole Derivatives as Antiviral Agents: An Overview. Molecules 2019;24:E1912. [PMID: 31109016 DOI: 10.3390/molecules24101912] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 8.7] [Reference Citation Analysis]
13 Edeh MO, Dalal S, Dhaou IB, Agubosim CC, Umoke CC, Richard-Nnabu NE, Dahiya N. Artificial Intelligence-Based Ensemble Learning Model for Prediction of Hepatitis C Disease. Front Public Health 2022;10:892371. [PMID: 35570979 DOI: 10.3389/fpubh.2022.892371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Anwar MF, Khalid R, Hasanain A, Naeem S, Zarina S, Abidi SH, Ali S. Application of an integrated cheminformatics-molecular docking approach for discovery for physicochemically similar analogs of fluoroquinolones as putative HCV inhibitors. Comput Biol Chem 2020;84:107167. [PMID: 31855781 DOI: 10.1016/j.compbiolchem.2019.107167] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Speck-Planche A, Dias Soeiro Cordeiro MN. Speeding up Early Drug Discovery in Antiviral Research: A Fragment-Based in Silico Approach for the Design of Virtual Anti-Hepatitis C Leads. ACS Comb Sci 2017;19:501-12. [PMID: 28437091 DOI: 10.1021/acscombsci.7b00039] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 9.4] [Reference Citation Analysis]
16 Elaziz MA, Moemen YS, Hassanien AE, Xiong S. Quantitative Structure-Activity Relationship Model for HCVNS5B inhibitors based on an Antlion Optimizer-Adaptive Neuro-Fuzzy Inference System. Sci Rep 2018;8:1506. [PMID: 29367667 DOI: 10.1038/s41598-017-19122-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
17 El Hassab MA, Ibrahim TM, Al-Rashood ST, Alharbi A, Eskandrani RO, Eldehna WM. In silico identification of novel SARS-COV-2 2'-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches. J Enzyme Inhib Med Chem 2021;36:727-36. [PMID: 33685335 DOI: 10.1080/14756366.2021.1885396] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
18 Asiri YI, Alsayari A, Muhsinah AB, Mabkhot YN, Hassan MZ. Benzothiazoles as potential antiviral agents. J Pharm Pharmacol 2020;72:1459-80. [PMID: 32705690 DOI: 10.1111/jphp.13331] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
19 Ahmad S, Shahid F, Tahir Ul Qamar M, Rehman HU, Abbasi SW, Sajjad W, Ismail S, Alrumaihi F, Allemailem KS, Almatroudi A, Ullah Saeed HF. Immuno-Informatics Analysis of Pakistan-Based HCV Subtype-3a for Chimeric Polypeptide Vaccine Design. Vaccines (Basel) 2021;9:293. [PMID: 33801143 DOI: 10.3390/vaccines9030293] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
20 Venkatesan A, Prabhu Dass J F. Review on chemogenomic approaches towards hepatitis C viral targets. J Cell Biochem 2019;120:12167-81. [PMID: 30887580 DOI: 10.1002/jcb.28581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
21 Rohini K, Agarwal P, Preethi B, Shanthi V, Ramanathan K. Exploring the Lead Compounds for Zika Virus NS2B-NS3 Protein: an e-Pharmacophore-Based Approach. Appl Biochem Biotechnol 2019;187:194-210. [PMID: 29911269 DOI: 10.1007/s12010-018-2814-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 Shunmugam L, Soliman MES. Targeting HCV polymerase: a structural and dynamic perspective into the mechanism of selective covalent inhibition. RSC Adv 2018;8:42210-22. [DOI: 10.1039/c8ra07346e] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
23 Anwar MF, Khalid R, Hasanain A, Naeem S, Zarina S, Abidi SH, Ali S. Integrated Cheminformatics-Molecular Docking Approach to Drug Discovery Against Viruses. Infect Disord Drug Targets 2020;20:150-9. [PMID: 30345931 DOI: 10.2174/1871526518666181019162359] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Sesmero E, Brown JA, Thorpe IF. Molecular simulations to delineate functional conformational transitions in the HCV polymerase. J Comput Chem 2017;38:1125-37. [PMID: 27859387 DOI: 10.1002/jcc.24662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Simon L, Abdul Salam AA, Madan Kumar S, Shilpa T, Srinivasan KK, Byrappa K. Synthesis, anticancer, structural, and computational docking studies of 3-benzylchroman-4-one derivatives. Bioorg Med Chem Lett 2017;27:5284-90. [PMID: 29074256 DOI: 10.1016/j.bmcl.2017.10.026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
26 Ashraf MU, Iman K, Khalid MF, Salman HM, Shafi T, Rafi M, Javaid N, Hussain R, Ahmad F, Shahzad-Ul-Hussan S, Mirza S, Shafiq M, Afzal S, Hamera S, Anwar S, Qazi R, Idrees M, Qureshi SA, Chaudhary SU. Evolution of efficacious pangenotypic hepatitis C virus therapies. Med Res Rev 2019;39:1091-136. [PMID: 30506705 DOI: 10.1002/med.21554] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
27 El-hasab MAE, El-bastawissy EE, El-moselhy TF. Identification of potential inhibitors for HCV NS3 genotype 4a by combining protein–ligand interaction fingerprint, 3D pharmacophore, docking, and dynamic simulation. Journal of Biomolecular Structure and Dynamics 2018;36:1713-27. [DOI: 10.1080/07391102.2017.1332689] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
28 Serafim MSM, Dos Santos Júnior VS, Gertrudes JC, Maltarollo VG, Honorio KM. Machine learning techniques applied to the drug design and discovery of new antivirals: a brief look over the past decade. Expert Opin Drug Discov 2021;16:961-75. [PMID: 33957833 DOI: 10.1080/17460441.2021.1918098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]